, Volume 15, Issue 1–3, pp 145–155 | Cite as

Scale-up of the adenovirus expression system for the production of recombinant protein in human 293S cells

  • Alain Garnier
  • Johanne Côté
  • Isabelle Nadeau
  • Amine Kamen
  • Bernard Massie


Human 293S cells, a cell line adapted to suspension culture, were grown to 5×106 cells/mL in batch with calcium-free DMEM. These cells, infected with new constructions of adenovirus vectors, yielded as much as 10 to 20% recombinant protein with respect to the total cellular protein content. Until recently, high specific productivity of recombinant protein was limited to low cell density infected cultures of no more than 5×105 cells/mL. In this paper, we show with a model protein, Protein Tyrosine Phosphatase 1C how high product yield can be maintained at high cell densities of 2×106 cells/mL by a medium replacement strategy. This allows the production of as much as 90 mg/L of active recombinant protein per culture volume. Analysis of key limiting/inhibiting medium components showed that glucose addition along with pH control can yield the same productivity as a medium replacement strategy at high cell density in calcium-free DMEM. Finally, the above results were reproduced in 3L bioreactor suspension culture thereby establishing the scalability of this expression system. The process we developed is used routinely with the same success for the production of various recombinant proteins and viruses.

Key words

Adenovirus human 293S cells recombinant protein scale-up metabolism 



calcium-free DMEM


bovine calf serum


hours post-infection


enriched Joklik medium


major late promoter


multiplicity of infection (# of infectious viral particle/cell)


specific consumption rate (mole/cell.h)


plaque forming unit (# of infectious viral particle)


yield (μg/E6 cells or mole/cell)


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Berkner KL (1988) Development of adenovirus vectors for the expression of heterologous genes. Biotechniques 6:616–628.Google Scholar
  2. Berkner KL (1992) Expression of heterologous sequences in adenoviral vectors. Curr. Top. Microbiol. Immunol. 158:39–66.Google Scholar
  3. Chillakurur RA, Ryu DDY, Yilma T (1991) Propagation of recombinant vaccinia virus in HeLa cells: Adsorption kinetics and replication in batch cultures. Biotechnol. Prog. 7:85–92.Google Scholar
  4. Gerard RD and Meidell RS (1993) Adenovirus-mediated gene transfer. Trends Cardiovasc. Med. 5:171–177.Google Scholar
  5. Ginsberg HS (ed.) (1984) The adenoviruses. Plenum Publishing Corp., New-York.Google Scholar
  6. Gluzman Y, Reichl H and Solnick D (1982) Helper-free adenovirus type 5 vectors. In Eucaryotic viral Vectors, pp. 187–192. Edited by Y. Gluzman, New York: Cold Spring Harbor Laboratory.Google Scholar
  7. Graham FL, Smiley JR, Russell WC and Nairn R (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59–72.Google Scholar
  8. Graham FL (1987) Growth of 293 Cells in Suspension Culture. J. gen. Virol., 68: 937–940.Google Scholar
  9. Graham FL and Prevec I (1992) Adenovirus-based expression vectors and recombinant vaccines, p. 363–390. In RW Ellis (ed.), Vaccines: new approaches to immunological problems. Butterworth-Heinemann, Boston.Google Scholar
  10. Kamen A, Tom R, Caron A, Chavarie C, Massie B, Archambault J (1991) Culture of insect cells in a helical ribbon impeller bioreactor. Biotechnol. Bioeng., 38:619–628.Google Scholar
  11. Massie B, Dionne J, Lamarch N, Fleurent J, Langelier Y (1994) Improved adenovirus vector produces herpes simplex virus ribonucleotide reductase R1 and R2 subunits more efficiently than baculovirus vector. Submitted to Bio/Technology.Google Scholar
  12. O'Reilly KR, Miller LK and Luckow VA (1992) Baculovirus expression vectors, a laboratory manual. W.H. Freeman and Company, New-York.Google Scholar
  13. Shen S-H, Bastien L, Posner BI, Chrétien P (1991) A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature, 352: 736–739.Google Scholar
  14. Zhao Z, Bouchard P, Diltz CD, Shen S-H and Fischer EH (1993) Purification and characterization of a protein tyrosine phosphatase containing SH2 domains. J. Biol. Chem. 268:2816–2820.Google Scholar

Copyright information

© Kluwer Academic Publishers 1994

Authors and Affiliations

  • Alain Garnier
    • 1
  • Johanne Côté
    • 1
  • Isabelle Nadeau
    • 1
  • Amine Kamen
    • 1
  • Bernard Massie
    • 1
  1. 1.Institut de recherche en biotechnologieCNRCMontréalCanada

Personalised recommendations